Company Information

Company Profile

Cerecor is a clinical-stage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders. Cerecor's lead drug candidate is CERC-301, which Cerecor currently intends to explore as a novel treatment for orphan neurological indications.

Latest Presentation

Investor Presentation

View This Presentation
Investor Presentation

Contact Information

Investor Relations

Company Contact
Cerecor, Inc.
400 East Pratt Street
Baltimore, MD 21202